Go Pro

BrightSpring Health Services (BTSG) Competitors

BrightSpring Health Services logo
$55.78 -0.77 (-1.36%)
Closing price 04:00 PM Eastern
Extended Trading
$55.90 +0.13 (+0.22%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BTSG vs. DGX, LH, GH, TEM, and FMS

Should you buy BrightSpring Health Services stock or one of its competitors? BrightSpring Health Services's main competitors and comparable companies include Quest Diagnostics (DGX), Labcorp (LH), Guardant Health (GH), Tempus AI (TEM), and Fresenius Medical Care AG & Co. KGaA (FMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does BrightSpring Health Services compare to Quest Diagnostics?

Quest Diagnostics (NYSE:DGX) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, profitability, analyst recommendations, valuation, earnings and risk.

Quest Diagnostics has a net margin of 9.18% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Quest Diagnostics9.18% 16.01% 7.27%
BrightSpring Health Services 2.55%16.73%5.24%

In the previous week, Quest Diagnostics had 14 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for Quest Diagnostics and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat Quest Diagnostics' score of 0.52 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Quest Diagnostics
4 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Quest Diagnostics has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market.

88.1% of Quest Diagnostics shares are owned by institutional investors. 0.9% of Quest Diagnostics shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Quest Diagnostics has higher earnings, but lower revenue than BrightSpring Health Services. Quest Diagnostics is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Quest Diagnostics$11.04B2.33$992M$9.4224.70
BrightSpring Health Services$12.91B0.85$190.67M$1.6633.60

Quest Diagnostics presently has a consensus price target of $237.08, suggesting a potential upside of 1.87%. BrightSpring Health Services has a consensus price target of $70.71, suggesting a potential upside of 26.76%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts clearly believe BrightSpring Health Services is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

Summary

BrightSpring Health Services beats Quest Diagnostics on 10 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Labcorp?

Labcorp (NYSE:LH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, risk, valuation, earnings, institutional ownership, analyst recommendations, profitability and media sentiment.

Labcorp has higher revenue and earnings than BrightSpring Health Services. Labcorp is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Labcorp$14.35B1.72$876.50M$12.0925.14
BrightSpring Health Services$12.91B0.85$190.67M$1.6633.60

Labcorp has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market.

In the previous week, Labcorp had 15 more articles in the media than BrightSpring Health Services. MarketBeat recorded 17 mentions for Labcorp and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat Labcorp's score of 0.48 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Labcorp
5 Very Positive mention(s)
0 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Labcorp has a net margin of 6.99% compared to BrightSpring Health Services' net margin of 2.55%. Labcorp's return on equity of 16.74% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Labcorp6.99% 16.74% 7.81%
BrightSpring Health Services 2.55%16.73%5.24%

Labcorp currently has a consensus target price of $337.73, suggesting a potential upside of 11.12%. BrightSpring Health Services has a consensus target price of $70.71, suggesting a potential upside of 26.76%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts clearly believe BrightSpring Health Services is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Labcorp
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

95.9% of Labcorp shares are held by institutional investors. 0.8% of Labcorp shares are held by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Labcorp beats BrightSpring Health Services on 9 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Guardant Health?

Guardant Health (NASDAQ:GH) and BrightSpring Health Services (NASDAQ:BTSG) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends.

In the previous week, Guardant Health had 14 more articles in the media than BrightSpring Health Services. MarketBeat recorded 16 mentions for Guardant Health and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat Guardant Health's score of 0.21 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
6 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BrightSpring Health Services has a net margin of 2.55% compared to Guardant Health's net margin of -38.33%. BrightSpring Health Services' return on equity of 16.73% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-38.33% N/A -25.40%
BrightSpring Health Services 2.55%16.73%5.24%

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M24.09-$416.28M-$3.49N/A
BrightSpring Health Services$12.91B0.85$190.67M$1.6633.60

Guardant Health presently has a consensus price target of $188.13, indicating a potential upside of 6.70%. BrightSpring Health Services has a consensus price target of $70.71, indicating a potential upside of 26.76%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts plainly believe BrightSpring Health Services is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Guardant Health has a beta of 1.57, meaning that its stock price is 57% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, meaning that its stock price is 84% more volatile than the broader market.

Summary

BrightSpring Health Services beats Guardant Health on 12 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Tempus AI?

BrightSpring Health Services (NASDAQ:BTSG) and Tempus AI (NASDAQ:TEM) are both large-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, risk, media sentiment, profitability, valuation, dividends and earnings.

BrightSpring Health Services has a net margin of 2.55% compared to Tempus AI's net margin of -17.77%. BrightSpring Health Services' return on equity of 16.73% beat Tempus AI's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.55% 16.73% 5.24%
Tempus AI -17.77%-50.28%-10.33%

BrightSpring Health Services has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.72, suggesting that its stock price is 272% more volatile than the broader market.

BrightSpring Health Services presently has a consensus target price of $70.71, indicating a potential upside of 26.76%. Tempus AI has a consensus target price of $69.63, indicating a potential downside of 9.09%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts plainly believe BrightSpring Health Services is more favorable than Tempus AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10
Tempus AI
2 Sell rating(s)
9 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.41

BrightSpring Health Services has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.85$190.67M$1.6633.60
Tempus AI$1.27B10.87-$245.03M-$1.44N/A

In the previous week, Tempus AI had 38 more articles in the media than BrightSpring Health Services. MarketBeat recorded 40 mentions for Tempus AI and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat Tempus AI's score of 0.57 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tempus AI
17 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

24.2% of Tempus AI shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 24.3% of Tempus AI shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

BrightSpring Health Services beats Tempus AI on 12 of the 17 factors compared between the two stocks.

How does BrightSpring Health Services compare to Fresenius Medical Care AG & Co. KGaA?

BrightSpring Health Services (NASDAQ:BTSG) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, valuation, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

BrightSpring Health Services currently has a consensus target price of $70.71, indicating a potential upside of 26.76%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $23.57, indicating a potential upside of 5.04%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, equities research analysts plainly believe BrightSpring Health Services is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

BrightSpring Health Services has a beta of 1.84, indicating that its stock price is 84% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, BrightSpring Health Services had 1 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 2 mentions for BrightSpring Health Services and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.44 beat BrightSpring Health Services' score of 1.10 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.55% 16.73% 5.24%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.85$190.67M$1.6633.60
Fresenius Medical Care AG & Co. KGaA$19.43B0.62$1.11B$1.9311.62

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 11 of the 17 factors compared between the two stocks.

Get BrightSpring Health Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTSG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTSG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTSG vs. The Competition

MetricBrightSpring Health ServicesHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$11.04B$9.67B$7.20B$13.10B
Dividend YieldN/A2.61%2.53%13.00%
P/E Ratio33.6034.44274.5825.69
Price / Sales0.854.93644.0085.88
Price / Cash25.42121.8176.3152.02
Price / Book5.365.2010.446.32
Net Income$190.67M$315.70M$3.49B$359.73M
7 Day Performance-5.39%-1.36%0.51%1.35%
1 Month Performance-5.25%-2.74%-3.38%-3.68%
1 Year Performance99.36%11.52%16.04%5.56%

BrightSpring Health Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTSG
BrightSpring Health Services
4.6901 of 5 stars
$55.78
-1.4%
$70.71
+26.8%
+104.9%$11.04B$12.91B33.6023,500
DGX
Quest Diagnostics
4.1499 of 5 stars
$236.26
-3.5%
$237.08
+0.3%
+27.1%$26.11B$11.04B25.1157,000
LH
Labcorp
4.1313 of 5 stars
$313.67
-2.3%
$337.73
+7.7%
+11.3%$25.44B$13.95B25.9471,000
GH
Guardant Health
2.183 of 5 stars
$177.77
+2.2%
$188.13
+5.8%
+196.4%$23.88B$982.02MN/A2,506
TEM
Tempus AI
1.8581 of 5 stars
$77.82
-0.3%
$69.63
-10.5%
-10.1%$14.06B$1.27BN/A3,800

Related Companies and Tools


This page (NASDAQ:BTSG) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners